Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO in Primary Immune Thrombocytopenia
NCT02139501Phase 3Completed
- Sponsor
- Shandong University
- Start
- May 2014
- Primary completion
- Jan 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Shandong University. Started May 2014; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02139501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139501.